Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

NCT01164150 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

92

Enrollment

NETWORK

Sponsor class

Conditions

Endometrial Cancer
Gastrointestinal Complications
Radiation Toxicity
Urinary Complications

Interventions

RADIATION: 45 Gy/25 fractions

Sponsor

Cancer Trials Ireland